Director of Aseptic Production, Ireland

Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger

Gentofte

Are you ready to be part of building an entirely new Novo Nordisk production facility? To spearhead the Aseptic Production Process & Automation track? If you're ready for an exciting challenge and a chance to make a lasting impact and would like to relocate to Ireland keep on reading! Join our Team as responsible for the Aseptic Production track for the Fill & Finish (FF) Expansion Ireland Project! The position The Director of Aseptic Production plays a pivotal role within the FF Expansion Ireland project and is a key role integrated into the project management and execution team responsible for overseeing a critical and strategic expansion project. Furthermore, the position will be part of the management team for the Irish project. You have the following task:
  • Overall responsible for the process and automation installation, verification, and operational readiness of the aseptic production (AP) part of the facility.
  • Responsible for ensuring close collaboration with the AP Expansions program to implement the project-specific technical execution objectives and equipment.
  • A key driver in ensuring that the AP process and automation organization is recruited, ramped up, and sufficiently trained for operational readiness during the project phases.
  • You play a crucial role in facilitating the organization's full ownership of the AP facility, equipment, standards, and procedures.
  • Qualifications The Director of Aseptic Production possesses significant experience in pharmaceutical engineering, enabling a comprehensive understanding of strategic implications. You excel in proactively and efficiently managing complex operations and organizations. The ideal candidate:
  • Has experience in driving a major construction project and solid knowledge of pharmaceutical Aseptic Production.
  • Can achieve results according to project milestones, demonstrating efficient collaboration with multiple stakeholders at different levels.
  • You exhibit a motivating and inclusive management style, fostering a positive work environment and promoting collaboration among team members.
  • You are ready to relocate to Ireland.
  • About the department You will be joining Fill & Finish Expansions. The area is anchored in Product Supply, Quality & IT, which globally employ approximately 20,000 of Novo Nordisk’s 50,000 employees. Fill & Finish Expansions is a newly established and growing area with the responsibility to design, plan and build all major fill & finish expansion projects across PSQIT to serve the needs of millions of patients. We do it by rethinking our fill & finish facilities with the use of modern technology. We are setting the standards for the facilities of the future, designing facilities we will still be proud of 20 years from now. Fill & Finish Expansions has a global approach, where you will be working with multiple sites and cultures across the world. Working at Novo Nordisk At Novo Nordisk, we do not wait for change. We drive it. We are a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence, without fixating on perfection. We never shy away from opportunities to develop we seize them. From research and development to manufacturing, marketing, and sales – we’re all working to move the needle on patient care. Contact If you have any questions or need further information, please contact Project VP for site Ireland, Poul Henning Poulsen at +45 30 75 88 34. Deadline 27th of August 2023. Applications will be reviewed on an ongoing basis, so we encourage you to apply as soon as possible. You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo to your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.


    Information og data

    Denne ledige stilling har jobtypen "Øvrige", og befinder sig i kategorien "Øvrige stillinger".

    Arbejdsstedet er beliggende i Gentofte.

    Jobbet er oprettet på vores service den 20.7.2023, men kan have været deaktiveret og genaktiveret igen.

    Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
    • Øvrige
    • Gentofte

    Lignende jobs

    Statistik over udbudte jobs som øvrige i Gentofte

    Herunder ser du udviklingen i udbudte øvrige i Gentofte over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal øvrige.

    Se flere statistikker her:
    Statistik over udbudte øvrige over tid

    Dato Alle jobs som øvrige
    29. maj 2024 19
    28. maj 2024 22
    27. maj 2024 25
    26. maj 2024 25
    25. maj 2024 25
    24. maj 2024 25
    23. maj 2024 26
    22. maj 2024 28
    21. maj 2024 31
    20. maj 2024 31
    19. maj 2024 31
    18. maj 2024 31
    17. maj 2024 32
    16. maj 2024 29
    15. maj 2024 29
    14. maj 2024 30
    13. maj 2024 30
    12. maj 2024 27
    11. maj 2024 30
    10. maj 2024 31
    9. maj 2024 31
    8. maj 2024 28
    7. maj 2024 26
    6. maj 2024 34
    5. maj 2024 30
    4. maj 2024 36
    3. maj 2024 33
    2. maj 2024 28
    1. maj 2024 33
    30. april 2024 33
    29. april 2024 34